Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
C 50.36 0.30% 0.15
SNY closed up 0.3 percent on Thursday, July 18, 2024, on 1.44 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Jul 25
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Multiple of Ten Bullish Other 0.30%
Outside Day Range Expansion 0.30%
Gapped Down Weakness 0.30%
NR7 Range Contraction 0.62%
Narrow Range Bar Range Contraction 0.62%
Doji - Bullish? Reversal 0.62%
Multiple of Ten Bullish Other 0.62%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
60 Minute Opening Range Breakout about 21 hours ago
Rose Above Previous Day's High about 21 hours ago
Rose Above 10 DMA about 21 hours ago
10 DMA Resistance about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sanofi Description

Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Cancer Life Sciences Pharmaceutical Health Sciences Pain Phosphates Prostate Cancer Hypertension Kidney Disease Animal Health Dialysis Glucose Influenza Colorectal Cancer Healthcare Products Insulin Multiple Sclerosis Suspension Osteoarthritis Chronic Kidney Disease Health Care Products Veins Cac 40 Fever Hepatotoxins Platelet Thrombosis Meningitis Phosphorus Pompe Disease Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Gaucher Disease Pneumonia Regeneron Clopidogrel Glucose Meter

Is SNY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 53.4541
52 Week Low 40.8964
Average Volume 2,340,190
200-Day Moving Average 47.24
50-Day Moving Average 48.94
20-Day Moving Average 49.47
10-Day Moving Average 50.43
Average True Range 0.85
RSI (14) 56.52
ADX 23.47
+DI 36.18
-DI 23.92
Chandelier Exit (Long, 3 ATRs) 49.21
Chandelier Exit (Short, 3 ATRs) 48.92
Upper Bollinger Bands 51.92
Lower Bollinger Band 47.02
Percent B (%b) 0.68
BandWidth 9.91
MACD Line 0.60
MACD Signal Line 0.55
MACD Histogram 0.0493
Fundamentals Value
Market Cap 126.04 Billion
Num Shares 2.5 Billion
EPS 2.32
Price-to-Earnings (P/E) Ratio 21.71
Price-to-Sales 2.50
Price-to-Book 1.46
PEG Ratio 4.97
Dividend 3.76
Dividend Yield 7.47%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.89
Resistance 3 (R3) 50.90 50.73 50.80
Resistance 2 (R2) 50.73 50.60 50.73 50.77
Resistance 1 (R1) 50.55 50.52 50.47 50.54 50.74
Pivot Point 50.38 50.38 50.34 50.38 50.38
Support 1 (S1) 50.20 50.25 50.12 50.19 49.98
Support 2 (S2) 50.03 50.17 50.03 49.95
Support 3 (S3) 49.85 50.03 49.92
Support 4 (S4) 49.84